Overview Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke Status: Suspended Trial end date: 2016-12-01 Target enrollment: Participant gender: Summary This research is a Randomized, double-blind, placebo-controlled, multicenter clinical study. Chinese subjects with Ischemic Stroke. Phase: Phase 2 Details Lead Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.